Bharat Immunological & Biological Corporation Share Price

CMP as on24-May-22 15:31

₹ 28.75
0.2 0.7%

Open

₹ 29.05

Turnover (lac)

₹ 19

Prev. Close

₹ 28.55

Day's Vol (shares)

₹ 12,111

Day's Range

₹ 28.60
₹ 29.40

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Jan-2022 - -
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 8th February 2022 to approve the accounts of the Company for the quarter ended 31st December 2021. In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2021 approved by the Board of the Company in its Meeting on 08.02.2022. The XBRL filing will be made succeeding to this. (As per BSE Announcement Dated on 09/02/2022)
Board Meeting - 22-Oct-2021 - -
Quarterly Results In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter and half year ended September 2021 approved by the Board of the Company in its Meeting on 29.10.2021. (As per BSE Announcement Dated on 30/10/2021)
Board Meeting - 15-Jul-2021 - -
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2021 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 22nd July 2021, to approve the accounts of the Company for the period ended 31st March 2021. BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve It is submitted that the intimation for date of Board Meeting was submitted at Exchange for 22.07.2021. However due to unavoidable circumstances it has been postponed to 27.07.2021. (As per BSE Announcement Dated on 23/7/2021) In pursuance of the LODR with Stock Exchange, please find attached the Unaudited Quarterly Financial Results for the quarter ended June 2021approved by the Board of the Company in its Meeting on 27.07.2021. (As per BSE Announcement Dated on 27/7/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity